KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Shares Repurchased (2022 - 2025)

Tenet Healthcare's Shares Repurchased history spans 7 years, with the latest figure at $198.0 million for Q4 2025.

  • For Q4 2025, Shares Repurchased changed N/A year-over-year to $198.0 million; the TTM value through Dec 2025 reached $1.4 billion, up 106.25%, while the annual FY2025 figure was $1.4 billion, 106.25% up from the prior year.
  • Shares Repurchased for Q4 2025 was $198.0 million at Tenet Healthcare, up from $93.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $747.0 million in Q2 2025 and bottomed at $40.0 million in Q2 2023.
  • The 4-year median for Shares Repurchased is $198.0 million (2025), against an average of $228.0 million.
  • The largest annual shift saw Shares Repurchased tumbled 56.0% in 2023 before it surged 575.0% in 2024.
  • A 4-year view of Shares Repurchased shows it stood at $250.0 million in 2022, then crashed by 56.0% to $110.0 million in 2023, then rose by 12.73% to $124.0 million in 2024, then skyrocketed by 59.68% to $198.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Shares Repurchased are $198.0 million (Q4 2025), $93.0 million (Q3 2025), and $747.0 million (Q2 2025).